Comparing drug eluting balloons and stents for treating calcified nodules in coronary arteries
Official title: DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
Run by Fundación EPIC · NCT06657833 · Data updated 2026-11-12
This study is testing whether drug eluting balloons can work as well as drug eluting stents for treating calcified nodules in the coronary arteries of patients with heart conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Fundación EPIC Academic / other |
| Locations | 15 sites (Leiden and 14 other locations) |
| Status | Recruiting |
| Started | December 17, 2024 |
| Main results expected | October 30, 2027 |
| Study ends | October 30, 2027 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06657833 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with stable coronary artery disease or acute coronary syndromes and severe calcified lesions suitable for percutaneous coronary intervention.
✕Probably not a fit
Patients with life expectancy less than one year, those with left main stem lesions, or those previously treated with stents or DEB may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This international, multicenter trial investigates the effectiveness of drug eluting balloons (DEB) versus drug eluting stents (DES) in patients with calcified nodules in coronary arteries. Patients with stable coronary artery disease or acute coronary syndromes will be randomized to receive either DEB or DES after undergoing intravascular lithotripsy to modify the calcified plaque. The study aims to determine if DEB can provide similar or better outcomes in terms of lumen loss and gain compared to DES at a 6-month follow-up. The trial is designed to address the lack of data on the safety and efficacy of DEB in this specific patient population.
Why it matters
Potential benefit: If successful, this study could offer a less invasive treatment option for patients with calcified coronary lesions, potentially improving their outcomes.
How similar studies have gone: While there is some observational data on DEB performance in calcified lesions, this approach is relatively novel and lacks extensive prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients must meet all inclusion criteria: * Patients \>18 years admitted for stable coronary artery disease or acute coronary syndromes and indication for percutaneous coronary intervention (PCI) and * Severe coronary lesion with calcified nodule, confirmed with intracoronary imaging (optical coherence tomography or intravascular ultrasound) and; * Lesion to treat in a vessel between 2.5 and 4 mm. Exclusion Criteria: Patients must not meet any criteria * Inability to provide oral and written informed consent or unwillingness to come back for systematic angiographic follow-up. * Pregnant or breastfeeding patients. * Cardiogenic Shock or Cardiac arrest at the moment of the index procedure. * Impossibility to maintain double antiplatelet treatment during at least 1 month. * Life expectancy \<1 year. * Index lesion at left main stem. * Aorto-ostial lesion. * Target lesion previously treated with stents or DEB. * High thrombus burden in the target lesion (TIMI thrombus scale≥3).
Where it's running
-
Leiden University Medical Center
Leiden, Netherlands Recruiting -
Hospital Del Mar
Barcelona, Spain Recruiting -
Hospital Universitario de La Paz
Fuencarral-El Pardo, Spain Recruiting -
Hospital Universitario de Galdakao-Usansolo
Galdakao, Spain Recruiting -
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain Recruiting -
Hospital Universitario de León
León, Spain Recruiting
Show 9 more locations
-
Hospital Universitario 12 de Octubre
Madrid, Spain Recruiting -
Hospital Universitario Puerta de Hierro
Madrid, Spain Recruiting -
Hospital Clínico San Carlos
Moncloa-Aravaca, Spain Recruiting -
Hospital Universitario de Navarra
Pamplona, Spain Recruiting -
Hospital General Universitario de Valencia
Valencia, Spain Recruiting -
Hospital Universitario y Politécnico La Fe
Valencia, Spain Recruiting -
Hospital Clínico Universitario de Valladolid
Valladolid, Spain Recruiting -
Hospital Universitario de Vigo
Vigo, Spain Recruiting -
Hospital Universitario Miguel Servet
Zaragoza, Spain Recruiting
Study contacts
- Study coordinator: Fundacion Epic
- Email: iepic@fundacionepic.org
- Phone: 0034987225638
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.